Table 5 The evaluations of prognostic factors other than the presence of pneumothorax by the log-rank test
Progression-free survival (PFS) | Overall survival (OS) | ||||
|---|---|---|---|---|---|
Variants | n | Hazard ratio (95 % CI) | p-value | Hazard ratio (95 % CI) | p-value |
Age ≥ 60 yo | 19 | 0.64 (0.33–1.25) | 0.19 | 0.88 (0.40–1.92) | 0.74 |
Male gender | 30 | 1.01 (0.55–1.85) | 0.99 | 1.43 (0.69–2.96) | 0.34 |
Synovial sarcoma | 9 | 0.57 (0.24–1.35) | 0.17 | 0.58 (0.20–1.66) | 0.31 |
Hypertension+ | 10 | 0.44 (0.17–1.13) | 0.09 | 1.15 (0.43–3.03) | 0.79 |
Smoking history+ | 20 | 0.96 (0.51–1.80) | 0.89 | 1.41 (0.67–2.94) | 0.36 |
lung lesion+ | 41 | 1.18 (0.59–2.35) | 0.64 | 2.02 (0.77–5.30) | 0.15 |
Number of lung lesions ≥2 | 35 | 0.96 (0.52–1.78) | 0.90 | 1.06 (0.497–2.279) | 0.87 |
Maximum diameter of lung lesions ≥ 30 mm | 21 | 1.37 (0.75–2.51) | 0.30 | 1.40 (0.685–2.878) | 0.36 |